Author: Kwan, Jennifer Yin Yee; Lin, Liang-Tzung; Bell, Rachel; Bruce, Jeffrey P.; Richardson, Christopher; Pugh, Trevor J.; Liu, Fei-Fei
Title: Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients Cord-id: pad655x4 Document date: 2021_2_25
ID: pad655x4
Snippet: Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. By leveraging large-scale genome-wide transcriptional data of normal and malignant tissues from adults and children, we found evidence of increased expression of SARS-CoV-2 viral entry genes in the cancer state, particularly in respiratory, gastrointestinal, and genitourinary tract ti
Document: Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. By leveraging large-scale genome-wide transcriptional data of normal and malignant tissues from adults and children, we found evidence of increased expression of SARS-CoV-2 viral entry genes in the cancer state, particularly in respiratory, gastrointestinal, and genitourinary tract tissues, with decreased expression in pediatric vs. adult samples. Additionally, by interrogating the temporal effects of radiotherapy on human peripheral blood mononuclear and mucosal cells, we observed important treatment-related alterations in host innate immunity, specifically type I interferon responses. Overall, cancers enhance expression of critical viral entry genes, and innate viral defenses can be dysregulated transiently during radiation treatments. These factors may contribute to the observed increased susceptibility to SARS-CoV-2 entry and severity of COVID-19 in cancer patients.
Search related documents:
Co phrase search for related documents- accumulate continue and acute respiratory syndrome: 1, 2
- activator activity and acute ards respiratory distress syndrome: 1, 2
- activator activity and acute respiratory syndrome: 1, 2, 3
- active infection and acute ards respiratory distress syndrome: 1, 2, 3, 4
- active infection and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- active infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activity carbohydrate and acute respiratory syndrome: 1
- activity carbohydrate and low expression: 1
- activity peptidase and acute disease: 1
- activity peptidase and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and low express: 1
- acute ards respiratory distress syndrome and low expression: 1, 2, 3, 4, 5, 6, 7
- acute disease and low expression: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and low express: 1, 2, 3
- acute respiratory syndrome and low expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date